Revenue, last quarter
$78M
+13% vs same quarter last year
Net income
−$12.5M
+20.5% vs same quarter last year
EPS, diluted
−$0.19
+20.8% vs same quarter last year
Operating cash flow
−$1.9M
+86.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $297.2M | −$51.6M |
| FY24 | $266.3M | −$50.4M |
| FY23 | $202.1M | −$61.7M |
| FY22 | $148.6M | −$74.4M |
| FY21 | $99.7M | −$46.8M |
| FY20 | $56.5M | −$163M |
| FY19 | $34.9M | −$90M |
| FY18 | $0 | −$46.9M |
| FY17 | - | −$4.5M |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 66.3% | −11% | −17.4% |
| FY24 | 68.5% | −12.9% | −18.9% |
| FY23 | 68.1% | −24.4% | −30.5% |
| FY22 | 60.4% | −44% | −50.1% |
| FY21 | 56.3% | −44.6% | −47% |
| FY20 | 67.6% | −270.7% | −288.3% |
| FY19 | 77.1% | −283.3% | −257.8% |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$45.7M |
| FY24 | −$19.5M |
| FY23 | −$34.5M |
| FY22 | −$86.5M |
| FY21 | −$33.8M |
| FY20 | −$58.7M |
| FY19 | −$93.7M |
| FY18 | −$25.7M |
| FY17 | −$13.2M |
| FY16 | - |
- Evolus
- Healthcare median
Show the numbers
| Year | Evolus | Healthcare median |
|---|---|---|
| FY25 | −17.4% | −30.6% |
| FY24 | −18.9% | −47% |
| FY23 | −30.5% | −58% |
| FY22 | −50.1% | −80.4% |
| FY21 | −47% | −71.8% |
| FY20 | −288.3% | −62.2% |
| FY19 | −257.8% | −46.2% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |